NCT01839058

Brief Summary

Non-cardiac chest pain (NCCP) is a common disorder whose pathophysiology is poorly understood. Some evidence suggests it may be related to sustained esophageal contractions (SECs) of longitudinal smooth muscle. The investigators have previously shown that acid is a trigger for SECs and results in shortening of the esophagus. In this study, the investigators plan to prospectively evaluate esophageal shortening responses to acid in a group of patients with NCCP compared to controls. The investigators will use high resolution esophageal manometry coupled with acid infusion to evaluate shortening. The investigators hypothesize that at least a subset of patients with NCCP will have an exaggerated esophageal shortening response to acid which correlates with symptom production. If our hypothesis proves true, this may lead to a future therapeutic target in the treatment of these patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 24, 2013

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

August 3, 2017

Completed
Last Updated

November 26, 2018

Status Verified

November 1, 2018

Enrollment Period

1 year

First QC Date

April 16, 2013

Results QC Date

April 25, 2017

Last Update Submit

November 23, 2018

Conditions

Keywords

Non Cardiac Chest Pain

Outcome Measures

Primary Outcomes (1)

  • Mean Change in Esophageal Length With Acid

    Mean length of esophagus with acid infusion minus mean length of esophagus with saline infusion

    Length at T= 20 minutes - Baseline (T=0)

Secondary Outcomes (3)

  • Esophageal Length at Symptom Onset

    20 minutes

  • Esophageal Length at Maximal Symptom Intensity

    20 minutes

  • Number of Participants for Whom a Correlation Was Found Between Symptom Onset and Esophageal Shortening

    20 minutes

Study Arms (2)

Non Cardiac Chest Pain Patients

Patients with Chest Pain where Coronary Artery Disease has been formally ruled out are to undergo esophageal manometry testing.

Other: Esophageal Manometry

Healthy Controls

Healthy volunteers without esophageal symptoms are to undergo esophageal manometry testing.

Other: Esophageal Manometry

Interventions

Both cohorts will undergo standard high resolution esophageal manometry testing. This entails a catheter passed through the nose into the esophagus and measures pressure changes with a series of wet swallows. As part of the study, we will also be instilling both weak acid and saline into the esophagus.

Healthy ControlsNon Cardiac Chest Pain Patients

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with non cardiac chest pain as diagnosed by cardiologist or other physician. Healthy Volunteers will include anyone in the Kingston area who fulfils Inclusion and Exclusion criteria.

You may qualify if:

  • Healthy volunteers:
  • free of esophageal symptoms
  • not on any acid suppressing medications
  • Non Cardiac Chest Pain Patients:
  • Angina like chest pain occuring at least once per month
  • Coronary artery disease ruled out by stress test or angiogram

You may not qualify if:

  • pre existing motility disorder of the esophagus
  • connective tissue disease
  • pregnancy
  • taking calcium channel blockers, Nitrates, Gabapentin, Narcotics, Tricyclic antidepressants, Anti seizure medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hotel Dieu Hospital

Kingston, Ontario, K7L 5G2, Canada

Location

Results Point of Contact

Title
Keith McIntosh
Organization
Western University

Study Officials

  • William Paterson, MD, FRCPC

    Queen's University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

April 16, 2013

First Posted

April 24, 2013

Study Start

October 1, 2013

Primary Completion

October 1, 2014

Study Completion

October 1, 2014

Last Updated

November 26, 2018

Results First Posted

August 3, 2017

Record last verified: 2018-11

Locations